Anzeige
Mehr »
Login
Montag, 21.04.2025 Börsentäglich über 12.000 News von 691 internationalen Medien
Gold auf 4.000 USD? Goldman Sachs sagen Ja - und bei Forge sitzt der Ex-CFO von Newmont mit am Tisch
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PWTA | ISIN: US21244X1090 | Ticker-Symbol: 2CVU
Siehe auch CONVATEC GROUP PLC
Frankfurt
17.04.25
08:03 Uhr
11,700 Euro
-0,200
-1,68 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CONVATEC GROUP PLC ADR Chart 1 Jahr
5-Tage-Chart
CONVATEC GROUP PLC ADR 5-Tage-Chart

Aktueller Chart CONVATEC GROUP PLC ADR Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
CONVATEC GROUP PLC ADR-Investoren interessieren sich auch für diese Wertpapiere
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 ResultsSAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative...
► Artikel lesen
PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA GuidanceSAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative...
► Artikel lesen
GeneDx Announces Preliminary 2024 Financial ResultsSTAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for...
► Artikel lesen
GeneDx Reports Third Quarter 2024 Financial Results and Business HighlightsSTAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third...
► Artikel lesen
Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial GuidanceReports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating...
► Artikel lesen
Alignment Healthcare Reports Third Quarter 2024 ResultsReports $692.4 million in total revenue, up 51.6% year-over-year Increases Medicare Advantage membership, up 57.7% year-over-year to approximately 182,300 members, beating third-quarter and year-end...
► Artikel lesen